Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on April 21, 2026

Apr. 21, 2026

QuestionPro Acquires Fathom to Lead in AI-Powered Open-Ended Analysis

Indeterminate GlobeNewswire

Apr. 21, 2026

Posifa Technologies Introduces PGS5100 Series Hydrogen Sensors for EV Battery Safety and Leak Monitoring

Indeterminate GlobeNewswire

Apr. 21, 2026

Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment

Indeterminate GlobeNewswire

Apr. 21, 2026

SportsReflector Debuts First Mobile AI Sports & Fitness Coach With Real-Time Video Analysis, Live AR, and Remote Coaching

Indeterminate GlobeNewswire

Apr. 21, 2026

Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors

Indeterminate GlobeNewswire

Apr. 21, 2026

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial

Indeterminate GlobeNewswire

Apr. 21, 2026

Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire

Apr. 21, 2026

MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution

Indeterminate GlobeNewswire

Apr. 21, 2026

Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

The Ungoverned Workforce: Cybersecurity Insiders Finds 92% Lack Visibility Into AI Identities

Indeterminate GlobeNewswire

Apr. 21, 2026

DocHub Expands PDF Editing Capabilities With The New Edit Text Feature

Indeterminate GlobeNewswire

Apr. 21, 2026

NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

IP Strategy Announces Reverse Stock Split

Indeterminate GlobeNewswire

Apr. 21, 2026

Forge Nano, U.S. Advanced Manufacturing Leader for AI-Era Chips and Defense Batteries, to List on NASDAQ through Merger with Archimedes Tech SPAC Partners II Co.

Indeterminate GlobeNewswire

Apr. 21, 2026

ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026

Indeterminate GlobeNewswire